期刊文献+

Furazolidone therapy for Helicobacter pylori:Is it effective and safe? 被引量:6

Furazolidone therapy for Helicobacter pylori:Is it effective and safe?
下载PDF
导出
摘要 Some aspects related with the use of furazolidone as a rescue therapy for Helicobacter pylori (H pylorl) infection should be remarked, especially regarding its potential oncologic risk. The inclusion of furazolidone in a treatment regimen for H pylori infection is, at least, controversial, and it does not appear to be safe. Some aspects related with the use of furazolidone as a rescue therapy for Helicobacter pylori(H pylori) infection should be remarked,especially regarding its potential oncologic risk.The inclusion of furazolidone in a treatment regimen for H pylori infection is,at least,controversial,and it does not appear to be safe.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2009年第15期1914-1915,共2页 世界胃肠病学杂志(英文版)
关键词 Helicobacter pylori THERAPY FURAZOLIDONE Rescue therapy 幽门螺杆菌 呋喃唑酮 治疗方案 安全 幽门螺旋杆菌感染
  • 相关文献

参考文献6

  • 1Ahmed HH,,El-Aziem SH,Abdel-Wahhab MA.Potential role of cysteine and methionine in the protection against hormonal imbalance and mutagenicity induced by furazolidone in female rats[].Toxicology.2008
  • 2Guilherme Eduardo Gonalves Felga,Fernando Marcuz Silva,Ricardo Correa Barbuti,Tomás Navarro-Rodriguez,Schlioma Zaterka,Jaime Natan Eisig.Quadruple therapy with furazolidone for retreatment in patients with peptic ulcer disease[J].World Journal of Gastroenterology,2008,14(40):6224-6227. 被引量:9
  • 3L. GATTA, A. ZULLO&#8224,</a>, F. PERNA, C. RICCI, V. DE FRANCESCO&#8225,</a>, A. TAMPIERI, V. BERNABUCCI, M. CAVINA, C. HASSAN&#8224,</a>, E. IERARDI&#8225,</a>, S. MORINI&#8224,</a> &amp,D. VAIRA.A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses[].Alimentary Pharmacology and Therapeutics.2005
  • 4Zullo A,Hassan C,De Francesco V,Lorenzetti R,Marignani M,Angeletti S,Ierardi E,Morini S.A third-line levofloxacin- based rescue therapy for Helicobacter pylori eradication[].Digestive and Liver Disease.2003
  • 5A Zullo,V Francesco,C Hassan,S Morini,D Vaira.The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis[].Gut.2007
  • 6Tatsuta,M.,Iishi,H.,Baba,M.Attenuating effect of the monoamine oxidase inhibitor furazolidone on the anti-carcinogenic effect of cysteamine on gastric carcinogenesis induced by n-methyl-n1-nitro-nitrosoguanidine in Wistar rats[].International Journal of Cancer.1991

二级参考文献34

  • 1[1]Marshall BJ,Warren JR.Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration.Lancet 1984; 1:1311-1315
  • 2[2]Malfertheiner P,Megraud F,O'Morain C,Bazzoli F,ElOmar E,Graham D,Hunt R,Rokkas T,Vakil N,Kuipers EJ.Current concepts in the management of Helicobacter pylori infection:the Maastricht Ⅲ Consensus Report.Gut 2007; 56:772-781
  • 3[3]Gisbert JP,Pajares JM.Review article:Helicobacter pylori infection and gastric outlet obstruction-prevalence of the infection and role of antimicrobial treatment.Aliment Pharmacol Ther 2002; 16:1203-1208
  • 4[4]Parente F,Cucino C,Bianchi Porro G.Treatment options for patients with Helicobacter pylori infection resistant to one or more eradication attempts.Dig Liver Dis 2003; 35:523-528
  • 5[5]Graham DY,Lew GM,Malaty HM,Evans DG,Evans DJ Jr,Klein PD,Alpert LC,Genta RM.Factors influencing the eradication of Helicobacter pylori with triple therapy.Gastroenterology 1992; 102:493-496
  • 6[6]Houben MH,van de Beek D,Hensen EF,Craen AJ,Rauws EA,Tytgat GN.A systematic review of Helicobacter pylori eradication therapy-the impact of antimicrobial resistance on eradication rates.Aliment Pharmacol Ther 1999; 13:1047-1055
  • 7[7]Mendonca S,Ecclissato C,Sartori MS,Godoy AP,Guerzoni RA,Degger M,Pedrazzoli J Jr.Prevalence of Helicobacterpylori resistance to metronidazole,clarithromycin,amoxicillin,tetracycline,and furazolidone in Brazil.Helicobacter 2000; 5:79-83
  • 8[8]White AH.Absorption,distribution,metabolism,and excretion of furazolidone.A review of the literature.Scand J Gastroenterol Suppl 1989; 169:4-10
  • 9[9]Fakheri H,Merat S,Hosseini V,Malekzadeh R.Lowdose furazolidone in triple and quadruple regimens for Helicobacter pylori eradication.Aliment Pharmacol Ther 2004; 19:89-93
  • 10[10]Altamirano A,Bondani A.Adverse reactions to furazolidone and other drugs.A comparative review.Scand J Gastroenterol Supp1 1989; 169:70-80

共引文献8

同被引文献45

引证文献6

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部